Evaluation of the Efficacy and Safety of Vonoprazan in Patients with Nonerosive Gastroesophageal Reflux Disease: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study

• Autores principales: Yoshikazu Kinoshita, MD, PhD (Autor), Yuuichi Sakurai, MPharm (Autor), Madoka Shiino, MPharm (Autor), Kentaro Kudou, MS (Autor), Akira Nishimura, BSc, MBA (Autor), Takuya Miyagi, MD, PhD (Autor), Katsuhiko Iwakiri, MD, PhD (Autor), Eiji Umegaki, MD, PhD (Autor), Kiyoshi Ashida, MD, PhD (Autor)
• Formato: Libro
• Publicado: Elsevier, 2016-01-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Background: For many patients, current treatments do not adequately resolve heartburn in nonerosive reflux disease (NERD). Objective: To compare vonoprazan and placebo with respect to the frequency and severity of heartburn in patients with NERD. Methods: This Phase III, double-blind, placebo-contro...